Machine Learning

PureStorage Case Study: TrialStat Supports Life-changing Clinical Trials


“TrialStat’s Unified eClinical Suite supports clinical trials for pharmaceuticals, vaccines, and medical devices by helping to capture and analyze millions of records during each trial. With FlashArray//X, TrialStat software gains the speed and real-time data access that researchers need.” Read the case study to find out why TrialStat has partnered with PureStorage and how the…

Read More

Benchmark Genome Study Demonstrates Accuracy of Artificial Intelligence in Rapidly Diagnosing Rare Diseases in Critically Ill Patients


Pivotal study led by Fabric Genomics and Rady Children’s Institute for Genomic Medicine demonstrates that artificial intelligence can enable the accurate and rapid clinical diagnosis of rare diseases in critically ill newborns based on whole-genome or whole-exome analyses Excerpt from the Press Release: OAKLAND, Calif. & SAN DIEGO, Calif.–(BUSINESS WIRE)–Fabric Genomics and Rady Children’s Institute…

Read More

Second Genome Announces Research Collaboration with Virginia Commonwealth University to Identify a Non-Invasive NASH Composite Biomarker


Second Genome, leveraging machine learning capabilities and patient samples from studies led by VCU School of Medicine Professor Dr. Arun Sanyal, to identify microbiome signals to diagnose patients with NASH who have advanced fibrosis BRISBANE, Calif., Sept. 23, 2021 /PRNewswire/ — Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision…

Read More

Researchers uncover evolutionary forces at play in the aging of the blood system and identify people at increased risk of blood cancer


Excerpt from the Press Release: Discovery could provide early warning for blood malignancies, triggering proactive screening and enabling early treatment Toronto – (August 17, 2021) As people age, mutations can build up in blood stem cells and their clones in a process known as age-related clonal hematopoiesis, or ARCH. ARCH can be a risk factor…

Read More

Stanford AI center’s new platform grants worldwide access to free medical imaging datasets


Excerpt from the Press Release: Stanford University is expanding its free repository of imaging and healthcare datasets for artificial intelligence researchers around the globe. The California school’s Center for Artificial Intelligence in Medicine and Imaging first opened in 2019 and has since amassed annotated datasets for more than 1 million images. AIMI is now partnering…

Read More

Peptilogics and Cerebras Systems Partner on AI Solutions to Advance the Future of Peptide Therapeutics


Excerpt from the Press Release: SUNNYVALE, Calif. & PITTSBURGH, Pa.–(BUSINESS WIRE)–Cerebras Systems, the pioneer in high performance artificial intelligence (AI) compute, and Peptilogics, a biotechnology platform company and an emerging leader in leveraging computation to design novel therapeutics, today announced a collaboration to accelerate the development cycle of peptide therapeutics through AI. Leveraging the revolutionary Cerebras…

Read More

Radical Reads: The First Canadian AI and Healthcare Market Map


Excerpt from the Press Release: Digital healthcare adoption has accelerated since the onset of the pandemic. In the first half of 2021, approximately $14.7B was invested in digital healthcare in the US, surpassing the total amount invested in 2020 (~$14B). Building on a world-class talent pool, AI startups are also booming in Canada with ~$1.4B raised in the first 6…

Read More

Elucid Presents Data Demonstrating Its AI Software Can Uniquely Quantify Key Drivers of Heart Attack and Stroke from Computed Tomography


Excerpt from the Press Release: BOSTON–(BUSINESS WIRE)–Elucid, a medical technology company developing AI software for physicians to optimize the treatment of patients with known or suspected vascular disease, announced today that its founder Andrew Buckler will present findings from two separate studies at the virtual Society of Cardiovascular Computed Tomography (SCCT) 16th Annual Scientific Meeting.…

Read More

Shattering cancer with quantum machine learning: A preview


Excerpt from the Article by Joe Geraci, Founder of Netramark. Machine learning has become a standard tool for medical researchers attempting to model disease in various ways, including building models to predict response to medications, classifying disease subtypes, and discovering new therapies. In this preview, we review a paper that utilizes quantum computation in order…

Read More

Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment


Excerpt from the Press Release: CAMBRIDGE, Mass. and WESTMINSTER, Colo., May 12, 2021 /PRNewswire/ — Leap Therapeutics (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, andFlagship Biosciences, the leader in data-centric pathology and tissue analysis, today announced that they have developed an image analysis RNAscope® assay that is being used successfully for prospective patient enrollment in a clinical trial.…

Read More